Correlation Between Aslan Pharmaceuticals and AN2 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and AN2 Therapeutics, you can compare the effects of market volatilities on Aslan Pharmaceuticals and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and AN2 Therapeutics.

Diversification Opportunities for Aslan Pharmaceuticals and AN2 Therapeutics

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aslan and AN2 is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and AN2 Therapeutics go up and down completely randomly.

Pair Corralation between Aslan Pharmaceuticals and AN2 Therapeutics

If you would invest  108.00  in AN2 Therapeutics on September 1, 2024 and sell it today you would earn a total of  59.00  from holding AN2 Therapeutics or generate 54.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Aslan Pharmaceuticals  vs.  AN2 Therapeutics

 Performance 
       Timeline  
Aslan Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aslan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Aslan Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
AN2 Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Aslan Pharmaceuticals and AN2 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aslan Pharmaceuticals and AN2 Therapeutics

The main advantage of trading using opposite Aslan Pharmaceuticals and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.
The idea behind Aslan Pharmaceuticals and AN2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences